INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
Subscribe
INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
SEARCH
SEARCH
advanced search
WEARABLES
EXPERT VIEW
Dr Greg Moakes
ADVANCING CANCER CARE THROUGH ON-BODY SUBCUTANEOUS INJECTIONS: THE ONCOLOGY COMMUNITY’S PERSPECTIVE
Dr Greg Moakes discusses the role that on-body delivery systems have to play in modernising the delivery of oncology drugs, digging into the survey results of over 200 attendees of the American Society of Clinical Oncology 2025 Global Meeting as to their opinions on the place of this pivotal technology in oncological practice.
WEARABLES
Dr Sylvine Raverdy-Wilson
BD (Becton Dickinson & Company)
DEVICE DESIGN TO ADDRESS USABILITY AND MITIGATE USE-RELATED RISKS – A MEDICAL AFFAIRS AND HUMAN FACTORS PERSPECTIVE
Dr Sylvine Raverdy-Wilson deep dives into the device constituent of drug-device combination product design and shares perspectives through the Use-Related Risk Analysis methodology with a focus on the BD Libertas™ Wearable Injector.
WEARABLES
Dr Chaoyoung Lee
TxSphere
VISTA BY TXSPHERE: TRAVERSING THE LIMITATIONS OF SMALL-VOLUME BIOLOGICS
Dr Chaoyoung Lee and Mike Stout unveil an innovative addition to TxSphere's wearable platform, Vista, designed to improve on efficiency goals, adapt to varied drug formulations and advance beyond the requirements of low-volume drug delivery.
WEARABLES
Peter Schmidt
ZwickRoell
INJECTING DRUGS DIRECTLY INTO THE BODY: HOW ON-BODY DELIVERY SYSTEMS ARE REVOLUTIONISING THERAPY
Peter Schmidt discusses the advantages of on-body delivery systems and what makes them special, going on to consider the significant role that they are expected to play in the future of injection technology for the pharmaceutical and medical fields, as well as the role that comprehensive testing plays in bringing this technology to patients.
WEARABLES
Nicholas Ciccarelli
Kymanox
ACCELERATING DEVELOPMENT OF ELECTROMECHANICAL DELIVERY SYSTEMS VIA MODULAR INTEGRATION
Nicholas Ciccarelli, Andrew King, Dr Marcus Herrmann and Dr Thomas Roschke, discuss the insights gained in the product development process from the recent collaboration between the two companies, with Kymanox managing the overall system integration and Johnson MedTech tackling the specific design of the drive system within the designated product specification.
EXPERT VIEW
Michael Boerner
SAFE AND SKIN-FRIENDLY MANUFACTURING OF MEDICAL WEARABLES WITH ULTRASONIC WELDING
Michael Boerner looks at the key factors for designing skin-friendly medical wearables and how to manufacture them safely, automatically and sustainably.
INDUSTRIALISATION
Philipp Richard
Ypsomed
SELF-INJECTION DEVICE MANUFACTURING IN A DYNAMIC WORLD
Philipp Richard scrutinises the efficient production of self-injection devices in the pharma industry and describes Ypsomed’s own platforms for developing these devices, highlighting the need to be adaptable and resilient to the rapidly evolving world of drug development. He provides valuable insights into the ways in which the flexible manufacture of self-injection devices might be achieved.
WEARABLES
Mary Lou Glotzbach
Grand River Aseptic Manufacturing
THE POWER OF PARTNERSHIP AND CLOSE COLLABORATION FOR FILLING ON-BODY INJECTORS
Mary Lou Glotzbach and Dr Greg Moakes consider the implications of the increasing demand for high-volume injections across the drug delivery industry, and how technologies such as wearable injectors are creating novel challenges for the fill-finish process due to the novel containers involved, making the case that it is only through clear communication and close collaboration between partners that these challenges can be met and surmounted.
INJECTION
Jimmy Fan
CC Bio
Product Showcase: CCBIO’S INJECTOR PLATFORM PRODUCTS
CCBio’s expanding portfolio of self-injection devices reflects the growing importance of at-home administration in driving adherence across a range of therapies. This showcase explores the clinical rationale behind self-injection and details CCBio’s latest innovations, including electronic-assisted devices and Taiwan-based automated assembly.
SUSTAINABILITY
Stevanato Group
UNDERSTANDING PATIENT PREFERENCES FOR SUSTAINABLE ON-BODY DELIVERY SYSTEMS
Stevanato Group examines how semi-reusable, modular designs like its Vertiva
10 mL on-body delivery system can reconcile patient demands for ease of use with growing expectations for sustainability, sharing new UK preference data and lifecycle analysis that reveal significant waste and emissions reductions.
INJECTION
Dr Andreas Schneider
Ypsomed
THE RISE OF LARGE-VOLUME SUBCUTANEOUS ADMINISTRATION OF BIOPHARMACEUTICALS, AND DELIVERY IMPLICATIONS
Andreas Schneider and Jakob Lange consider the SC administration of larger volumes of biopharmaceuticals in the pharma industry and summarise a recent study that reviews clinical-stage and approved IV and SC biopharmaceuticals to provide valuable guidance for new product development, as well as for marketing and commercialisation strategies in the rapidly evolving large-volume SC landscape.
EXPERT VIEW
Tom Oakley
DRUG DELIVERY TRENDS FOR 2025
Tom Oakley and Alex Vasiev look back at how the trends anticipated for 2024 played out in reality and look forward to four major trends expected to influence the drug delivery industry in 2025.
INJECTION
Mindy Katz
Eitan Medical
EMPOWERING PHARMA WITH INNOVATIVE INFUSION TECHNOLOGIES AMID US POLICY CHANGES
Mindy Katz and Michael Ratigan outline the implications for pharmaceutical manufacturers of recent US policy changes – and highlight how Eitan Medical’s portfolio of infusion solutions can offer support.
WEARABLES
Dr Hong-Jun Yeh
MicroMED Co Ltd
NOVEL SOLUTIONS FOR ULTRA-LARGE-VOLUME WEARABLE AND PORTABLE SUBCUTANEOUS INJECTORS
Dr Hong-Jun Yeh, Jiunn-Ru Lai and Tsung-Chieh Cheng discuss the need for novel approaches to the challenge of delivering high volumes of biologics while also addressing patient centricity, and introduce MicroMED’s two innovative gas-powered approaches that leverage micro-electromechanical systems to drive the injection.
INJECTION
Thomas Fontanellaz
Ypsomed
SUBCUTANEOUS DRUG DELIVERY: ADAPTING TO HIGH-VISCOSITY, LARGE-VOLUME DEMANDS
Thomas Fontanellaz, Reto Jost and Andreas Schneider discuss how Ypsomed is addressing the growing need for subcutaneous injections that accommodate higher volumes and viscosities, with innovative self-injection devices designed to enhance patient comfort and adherence.
INJECTION
Emilie Aranda
RPK Medical
SPRINGS: THE KEY TO ADVANCED AUTOINJECTOR AND PEN INJECTOR PERFORMANCE
Emilie Aranda and Fernando González discuss the crucial role of spring mechanisms and other metal parts in autoinjectors and pen injectors.
EXPERT VIEW
Kyle Toole
DEFINING HIGH-VISCOSITY, LARGE-VOLUME DRUG DELIVERY SYSTEMS
Kyle Toole, Blair Hutton and James McLusky discuss the value that mathematical modelling can provide in the early stages of injectable drug delivery device development, especially when coupled with appropriate empirical testing in a laboratory setting.
WEARABLES
Dr Leonard Chu
Altek Medical
ENABLING LARGE-VOLUME SUBCUTANEOUS INJECTION WITH A SMART WEARABLE INJECTION PLATFORM
Leonard Chu presents the Altek Biotechnology's Alby injection platform and highlights its versatility as a delivery platform for large-volume subcutaneous injections.
WEARABLES
Dr Greg Moakes
LTS
TRUST THE PROGRESS: INTRODUCING AUTOMATION TO ENHANCE ON-BODY INJECTOR MANUFACTURING
Greg Moakes and Tzach Sadi the process and benefits of automating the production process for its on-body injector device, Sorrel™.
WEARABLES
Cecile Gross
Nemera
SYMBIOZE
®
: LARGE-VOLUME ON-BODY INJECTOR PLATFORM FOSTERING PATIENTS’ EXPERIENCE
Cécile Gross and Mark Tunkel discuss the how Nemera's on-body injector platform – Symbioze
®
– has been developed by drawing on a combination of lessons learned from the history of injection devices and the company’s extensive experience developing drug delivery devices for the parenteral route.
WEARABLES
Anna Allegro
Stevanato Group
UNLOCKING OPPORTUNITIES IN ON-BODY DELIVERY SYSTEMS THROUGH A PLATFORM TECHNOLOGY APPROACH
Anna Allegro and Andrea Cuccato discuss how Stevanato’s Vertiva
®
on-body delivery system exemplifies a platform technology approach to device design, with its 3 and 10 mL formats providing the flexibility necessary to accommodate a wide variety of therapies.
WEARABLES
Simon Bürdel
Gerresheimer
THE IMPORTANCE OF USER-CENTRIC DESIGN WHEN DEVELOPING DEVICES FOR HOME USE
Simon Bürdel and Reza Abedian, discuss the importance and value of conducting human factors studies and user consultations above and beyond regulatory requirements when designing user-centric devices for subcutaneous self-injection in at-home settings.
WEARABLES
Jimmy Fan
CC Bio
CCBio’s Quick Dose On-Body Injector
Quick Dose is a reusable on-body injector designed and developed to address the challenges of drug container compatibility and extend the lifecycle. The device aims to provide a more efficient and comfortable drug delivery method for patients and meet evolving market needs.
WEARABLES
Peter Schmidt
ZwickRoell
FROM PRECISION TO PERFECTION: NEW ON-BODY DELIVERY SYSTEM TESTING SOLUTIONS
Peter Schmidt details the advantages ZwickRoell’s integrated testing systems offer for ensuring precise and accurate testing of on-body drug delivery systems, including the prevention of static charge and the company’s advanced camera-based measurement systems.
Prev
1
2
3
4
…
12
Next
Top
